4//SEC Filing
Bush Tia L 4
Accession 0001847903-24-000184
CIK 0001847903other
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 5:11 PM ET
Size
10.8 KB
Accession
0001847903-24-000184
Insider Transaction Report
Form 4
Bush Tia L
Chief Technology & Quality Ofc
Transactions
- Exercise/Conversion
Ordinary Shares
2024-12-17$3.85/sh+17,813$68,580→ 165,428 total - Exercise/Conversion
Share Option (right to buy)
2024-12-17−17,813→ 27,187 totalExercise: $3.85Exp: 2033-02-01→ Ordinary Shares (17,813 underlying) - Sale
Ordinary Shares
2024-12-16$16.36/sh−9,611$157,256→ 147,615 total - Sale
Ordinary Shares
2024-12-17$18.00/sh−17,813$320,634→ 147,615 total
Footnotes (4)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 14, 2024.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.05 to $16.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F4]1/48th of the shares subject to such option shall vest and become exercisable in equal monthly installments with the first installment vesting on March 1, 2023.
Documents
Issuer
Centessa Pharmaceuticals plc
CIK 0001847903
Entity typeother
Related Parties
1- filerCIK 0001863418
Filing Metadata
- Form type
- 4
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 5:11 PM ET
- Size
- 10.8 KB